Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 2
2011 1
2015 1
2021 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Normal B cells express ZAP70 in chronic lymphocytic leukemia: A link between autoimmunity and lymphoproliferation?
Ghergus D, Martin M, Knapp AM, Delmotte F, Joublin-Delavat A, Jung S, Schickel JN, Mendel I, Dupuis A, Drénou B, Ghesquières H, Salles G, Baseggio L, Herbrecht R, Korganow AS, Vallat L, Soulas-Sprauel P, Meffre E, Martin T. Ghergus D, et al. Among authors: mendel i. Am J Hematol. 2024 Jan;99(1):48-56. doi: 10.1002/ajh.27137. Epub 2023 Oct 19. Am J Hematol. 2024. PMID: 37853951
Age of transfused blood in critically ill adults.
Lacroix J, Hébert PC, Fergusson DA, Tinmouth A, Cook DJ, Marshall JC, Clayton L, McIntyre L, Callum J, Turgeon AF, Blajchman MA, Walsh TS, Stanworth SJ, Campbell H, Capellier G, Tiberghien P, Bardiaux L, van de Watering L, van der Meer NJ, Sabri E, Vo D; ABLE Investigators; Canadian Critical Care Trials Group. Lacroix J, et al. N Engl J Med. 2015 Apr 9;372(15):1410-8. doi: 10.1056/NEJMoa1500704. Epub 2015 Mar 17. N Engl J Med. 2015. PMID: 25853745 Free article. Clinical Trial.
Specification and Evaluation of Plasticizer Migration Simulants for Human Blood Products: A Delphi Study.
Thelliez A, Hénard G, Delorme B, Chatellier S, Danel C, Ducoroy L, Dupont A, Garrigue D, Genay S, Goossens JF, Goossens L, Havet C, Hecq JD, Maeght C, Mendel I, Najdovski T, Odou P, Saint-Lorant G, Ung A, Lecoeur M, Décaudin B. Thelliez A, et al. Among authors: mendel i. Biomolecules. 2021 Jul 22;11(8):1081. doi: 10.3390/biom11081081. Biomolecules. 2021. PMID: 34439748 Free PMC article.
Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3-year period.
Cazenave JP, Isola H, Waller C, Mendel I, Kientz D, Laforêt M, Raidot JP, Kandel G, Wiesel ML, Corash L. Cazenave JP, et al. Among authors: mendel i. Transfusion. 2011 Mar;51(3):622-9. doi: 10.1111/j.1537-2995.2010.02873.x. Epub 2010 Sep 16. Transfusion. 2011. PMID: 20849406
An active hemovigilance program characterizing the safety profile of 7483 transfusions with plasma components prepared with amotosalen and UVA photochemical treatment.
Cazenave JP, Waller C, Kientz D, Mendel I, Lin L, Jacquet M, Propst M, Liu W, Corash L, Sundin D, Defoin L, Messe N, Osselaer JC. Cazenave JP, et al. Among authors: mendel i. Transfusion. 2010 Jun;50(6):1210-9. doi: 10.1111/j.1537-2995.2009.02579.x. Epub 2010 Jan 22. Transfusion. 2010. PMID: 20113450 Clinical Trial.